Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex

American Journal of Physical Medicine and Rehabilitation

Volumn 81, Issue 11 SUPPL., 2002, Pages

  Petrof, Basil J ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Congenital muscular dystrophy; Duchenne muscular dystrophy; Dystroglycans; Dystrophin; Limb girdle muscular dystrophy; Merosin; Sarcoglycans

Indexed keywords

CALCIUM; GENES; MUSCLE; MUTAGENESIS; PHYSIOLOGY; PROTEINS;

DYSTROPHY;

PATIENT REHABILITATION;

CALCIUM; DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; MEROSIN; SARCOGLYCAN;

CALCIUM TRANSPORT; COMPLEX FORMATION; CONFERENCE PAPER; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MOLECULAR BIOLOGY; MUSCLE INJURY; MUSCLE ISCHEMIA; MUSCULAR DYSTROPHY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN DEFICIENCY; SARCOLEMMA; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CYTOSKELETAL PROTEINS; DYSTROPHIN; HUMANS; MEMBRANE GLYCOPROTEINS; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; MYOFIBRILS; OXIDATIVE STRESS; SARCOLEMMA;

EID: 0036839039     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-200211001-00017     Document Type: Conference Paper

References (138)

1. Hoffman EP, Brown RHJ, Kunkel LM: Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-28
2. Ahn AH, Kunkel LM: The structural and functional diversity of dystrophin. Nat Genet 1993;3:283-91
3. Ervasti JM, Campbell KP: Membrane organization of the dystrophin-glycoprotein complex. Cell 1991;66:1121-31
4. Ervasti JM, Campbell KP: A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-23
5. Ozawa E, Yoshida M, Suzuki A, et al: Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 1995;4: 1711-6
6. Worton R: Muscular dystrophies: Diseases of the dystrophin-glycoprotein complex. Science 1995;270:755-6
7. Tinsley JM, Blake DJ, Zuellig RA, et al: Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA 1994;91:8307-3
8. Cohn RD, Campbell KP: Molecular basis of muscular dystrophies. Muscle Nerve 2000;23:1456-71
9. Koenig M, Monaco AP, Kunkel LM: The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 1988;53:219-26
10. Rybakova IN, Amann KJ, Ervasti JM: A new model for the interaction of dystrophin with F-actin. J Cell Biol 1996; 135:661-72
11. Yoshida M, Hama H, Ishikawa-Sakurai M, et al: Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum Mol Genet 2000;9:1033-40
12. Sadoulet-Puccio HM, Rajala M, Kunkel LM: Dystrobrevin and dystrophin: An interaction through coiled-coil motifs. Proc Natl Acad Sci U S A 1997;94:12413-8
13. Blake DJ, Nawrotzki R, Peters MF, et al: Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J Biol Chem 1996;271:7802-10
14. Jarrett HW, Foster JL: Alternate binding of actin and calmodulin to multiple sites on dystrophin. J Biol Chem 1995;270:5578-86
15. Yang B, Jung D, Motto D, et al: SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 1995;270: 11711-4
16. Hasegawa M, Cuenda A, Spillantini MG, et al: Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin: A mechanism for specific substrate recognition. J Biol Chem 1999;274:12626-31
17. Brennan JE, Chao DS, Xia H, et al: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995;85:743-52
18. Allamand V, Campbell KP: Animal models for muscular dystrophy: Valuable tools for the development of therapies. Hum Mol Genet 2000;9:2459-67
19. Grady RM, Grange RW, Lau KS, et al: Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1999;1:215-20
20. Lebakken CS, Venzke DP, Hrstka RF, et al: Sarcospan-deficient mice maintain normal muscle function. Mol Cell Biol 2000;20:1669-77
21. Kameya S, Miyagoe Y, Nonaka I, et al: α1-Syntrophin gene disruption results in the absence of neuronal-type nitric oxide synthase at the sarcolemma but does not induce muscle degeneration. J Biol Chem 1999;274:2193-200
22. Adams ME, Kramarcy N, Krall SP, et al: Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin. J Cell Biol 2000;150:1385-97
23. Vachon PH, Xu H, Liu L, et al: Integrins (alpha7beta1) in muscle function and survival: Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest 1997;100:1870-81
24. Chasis JA, Agre P, Mohandas N: Decreased membrane mechanical stability and in vivo loss of surface area reflect spectrin deficiencies in hereditary spherocytosis. J Clin Invest 1988;82:617-23
25. Waugh RE, Agre P: Reductions of erythrocyte membrane viscoelastic coefficients reflect spectrin deficiencies in hereditary spherocytosis. J Clin Invest 1988;81:133-41
26. Porter GA, Dmytrenko GM, Winkelmann JC, et al: Dystrophin colocalizes with beta-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J Cell Biol 1992;117:997-1005
27. Masuda T, Fujimaki N, Ozawa E, et al: Confocal laser microscopy of dystrophin localization in guinea pig skeletal muscle fibers. J Cell Biol 1992;119:543-8
28. Pierobon-Bormioli S: Transerve sarcomere filamentous systems: "Z- and Mcables." J Muscle Res Cell Motil 1981;2:401-13
29. Street SF: Lateral transmission of tension in frog myofibers: A myofibrillar network and transverse cytoskeletal connections are possible transmitters. J Cell Physiol 1983;114:346-64
30. Shear CR, Bloch RJ: Vinculin in subsarcolemmal densities in chicken skeletal muscle: Localization and relationship to intracellular and extracellular structures. J Cell Biol 1985;101:240-56
31. Pardo JV, Siliciano JD, Craig SW: A vinculin-containing cortical lattice in skeletal muscle: Traverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci USA 1983;80:1008-12
32. Small V, Furst DO, Thornell LE: The cytoskeletal lattice of muscle cells. Eur J Biochem 1992;208:559-72
33. Rybakova IN, Patel JR, Ervasti JM: The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol 2000;150:1209-14
34. Samitt CE, Bonilla E: Immunocytochemical study of dystrophin at the myotendinous junction. Muscle Nerve 1990;13:493-500
35. Tidball JG, Law DJ: Dystrophin is required for normal thin filament-membrane associations at myotendinous junctions. Am J Pathol 1991;138:17-21
36. Pasternak C, Wong S, Elson EL: Mechanical function of dystrophin in muscle cells. J Cell Biol 1995;128:355-61
37. Menke A, Jockusch H: Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 1991;349:69-71
38. Petrof BJ, Shrager JB, Stedman HH, et al: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993;90:3710-4
39. Moens P, Baatsen PH, Marechal G: Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 1993;14:446-51
40. Hack AA, Lam MYJ, Cordier L, et al: Differential requirements for individual sarcoglycans and dystrophin in the assembly and function of the dystrophinglycoprotein complex. J Cell Sci 2000;113:2535-44
41. Greelish JP, Su CH, Lankford EB, et al: Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adenoassociated viral vector. Nat Med 1999;5:439-43
42. Hack AA, Cordier L, Shoturma DI, et al: Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci USA 1999;96:10723-8
43. Weller B, Karpati G, Carpenter S: Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci 1990;100:9-13
44. Clarke MFC, Khakee R, McNeil PL: Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J Cell Sci 1993;106:121-33
45. Vilquin JT, Brussee V, Asselin I, et al: Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve 1998;21:567-76
46. Brussee V, Tardif F, Tremblay JP: Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord 1997;7:487-92
47. McCully K, Giger U, Argov Z, et al: Canine X-linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy. Muscle Nerve 1991;14:1091-8
48. Sacco P, Jones DA, Dick JR, et al: Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci 1992;82:227-36
49. Stedman HH, Sweeney HL, Shrager JB, et al: The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991;352:536-9
50. Shrager JB, Stedman HH, Sweeney HL, et al: The mdx mouse and mdx diaphragm: Implications for the pathogenesis of Duchenne muscular dystrophy, in Kelly AM, Blau HM (eds): Neuromuscular Development and Disease. New York, Raven Press, 1992, pp 317-28
51. Cox GF, Kunkel LM: Dystrophies and heart disease. Curr Opin Cardiol 1997;12:329-43
52. Melacini P, Fanin M, Danieli GA, et al: Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 1996;94:3168-75
53. Cziner DG, Levin RI: The cardiomyopathy of Duchenne's muscular dystrophy and the function of dystrophin. Med Hypotheses 1993;40:169-73
54. Grady RM, Teng H, Nichol MC, et al: Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: A model for Duchenne muscular dystrophy. Cell 1997;90:729-38
55. Bridges LR: The association of cardiac muscle necrosis and -inflammation with the degenerative and persistent myopathy of mdx mice. J Neurol Sci 1986;72:147-57
56. Torres LFB, Duchen LW: The mutant mdx: Inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 1987;110:269-99
57. Anderson JE, Kardami E: The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: Greater dystrophy in cardiac and soleus muscle. Muscle Nerve 1994;17:64-73
58. Megeney LA, Kablar B, Perry RLS, et al: Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc Natl Acad Sci USA 1999;96:220-5
59. Danialou G, Comtois AS, Dudley R, et al: Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J 2001;15:1655-7
60. Bodensteiner JB, Engel AB: Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: A study of 567,000 muscle fibers in 114 biopsies. Neurology 1978;28:439-46
61. 2+ metabolism in Duchenne muscular dystrophy: Effects on cellular and viral growth. Proc Natl Acad Sci USA 1984;81:7617-21
62. ++ at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients. Neurology 1988;38:476-80
63. Turner PR, Westwood T, Regen CM, et al: Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 1988;335:735-8
64. Gailly P, Boland B, Himpens B, et al: Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium 1993;14:473-83
65. Head SI: Membrane potential, resting calcium and calcium transients in isolated muscle fibres from normal and dystrophic mice. J Physiol 1993;469:11-9
66. 2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in mdx mouse muscle fibres. Pflugers Arch 1994;426:499-505
67. Rivet-Bastide M, Imbert N, Cognard C, et al: Changes in cytosolic resting ionized calcium level and in calcium transients during in vitro development of normal and Duchenne muscular dystrophy cultured skeletal muscle measured by laser cytofluorimetry using indo-1. Cell Calcium 1993;14:563-71
68. Hopf FW, Turner PRD Jr, Reddy P, et al: A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. Am J Physiol 1996;271:1325-39
69. + channels. Proc Natl Acad Sci USA 2000;97:4950-5
70. Alderton JM, Steinhardt RA: How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc Med 2000;10:268-72
71. Fong P, Turner PR, Denetclaw WF, et al: Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 1990;250:673-766
72. Franco A Jr, Lansman JB: Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 1990;344:670-3
73. Turner PR, Fong P, Denetclaw WF, et al: Increased calcium influx in dystrophic muscle. J Cell Biol 1991;115:1701-12
74. Franco-Obregon A Jr, Lansman JB: Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice. J Physiol 1994;481:299-309
75. Alderton JM, Steinhardt RA: Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J Biol Chem 2000;275:9452-60
76. McCarter GC, Steinhardt RA: Increased activity of calcium leak channels caused by proteolysis near sarcolemmal ruptures. J Membr Biol 2000;176:169-74
77. Gee SH, Madhavan R, Levinson SR, et al: Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J Neurosci 1998;18:128-37
78. Schultz J, Hoffmuller U, Krause G, et al: Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels. Nat Struct Biol 1998;5:19-24
79. Henry MD, Campbell KP: Dystroglycan inside and out. Curr Opin Cell Biol 1999;11:602-7
80. Yoshida T, Pan Y, Hanada H, et al: Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes. J Biol Chem 1998;273:1583-90
81. Brown SC, Lucy JA: Dystrophin as a mechanochemical transducer in skeletal muscle. Bioessays 1993;15:413-9
82. 2+-calmodulin binds to the carboxyl-terminal domain of dystrophin. J Biol Chem 1996;271:6605-10
83. Shemanko CS, Sanghera JS, Milner RE, et al: Phosphorylation of the carboxyl terminal region of dystrophin by mitogen-activated protein (MAP) kinase. Mol Cell Biochem 1995;152:63-70
84. Madhavan R, Jarrett HW: Calmodulin-activated phosphorylation of dystrophin. Biochemistry 1994;33:5797-804
85. Michalak M, Fu SY, Milner RE, et al: Phosphorylation of the carboxyl-terminal region of dystrophin. Biochem Cell Biol 1996;74:431-7
86. cdc2 protein kinase. J Biol Chem 1993;268:21901-5
87. Senter L, Ceoldo S, Petrusa MM, et al: Phosphorylation of dystrophin: Effects on actin binding. Biochem Biophys Res Com 1995;206:57-63
88. Walsh MP, Busaan JL, Fraser ED, et al: Characterization of the recombinant C-terminal domain of dystrophin: Phosphorylation by calmodulin-dependent protein kinase II and dephosphorylation by type 2B protein phosphatase. Biochemistry 1995;34:5561-8
89. Iwata Y, Pan Y, Yoshida T, et al: Alphal-syntrophin has distinct binding sites for actin and calmodulin. FEBS Lett 1998;423:173-7
90. 2+ binding protein. Biochemistry 1997;36:1295-305
91. (2+)-calmodulin dependent protein kinase II. Biochim Biophys Acta 1999;1434:260-74
92. Brenman JE, Chao DS, Gee SH, et al: Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and αa1-syntrophin mediated by PDZ domains. Cell 1996;84:757-67
93. Chang WJ, Iannaccone ST, Lau KS, et al: Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA 1996;93:9142-7
94. Chao DS, Silvagno F, Bredt DS: Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J Neurochem 1998;71:784-9
95. Crosbie RH, Straub V, Yun H-Y, et al: mdx Muscle pathology is independent of nNOS perturbation. Hum Mol Genet 1998;7:823-9
96. Thomas GD, Sander M, Lau KS, et al: Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophindeficient skeletal muscle. Proc Natl Acad Sci USA 1998;95:15090-5
97. Williamson RA, Henry MD, Daniels KJ, et al: Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 1997;6:831-41
98. Cote PD, Moukhles H, Lindenbaum M, et al: Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet 1999;23:338-42
99. Gee SH, Montanaro F, Lindenbaum MH, et al: Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 6-3-1994;77:675-86
100. Russo K, Di Stasio E, Macchia G, et al: Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction. Biochem Biophys Res Commun 2000;274:93-8
101. Song KS, Scherer PE, Tang Z, et al: Expression of caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996;271:15160-5
102. Sotgia F, Lee JK, Das K, et al: Caveolin-3 directly interacts with the C-terminal tail of β-dystroglycan: Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000;275:38048-58
103. Chardin P, Cussac D, Maignan S, et al: The Grb2 adaptor. FEBS Lett 1995;369:47-51
104. Lowenstein EJ, Daly RJ, Batzer AG, et al: The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992;70: 431-42
105. Song KS, Li S, Okamoto T, et al: Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae micro-domains. J Biol Chem 1996;271:9690-7
106. Okamoto T, Schlegel A, Scherer PE, et al: Caveolins, a family of scaffolding proteins for organizing: "Preassembled signaling complexes" at the plasma membrane. J Biol Chem 1998;273:5419-22
107. Yamamoto H, Hagiwara Y, Mizuno Y, et al: Heterogenicity of dystrophin-associated proteins. J Biochem 1993;114:132-9
108. McNally EM, Duggan D, Gorospe JR, et al: Mutations that disrupt the carboxylterminus of gamma-sarcoglycan cause muscular dystrophy. Hum Mol Genet 1996;5:1841-7
109. Hack AA, Ly CT, Jiang F, et al: gamma-Sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 1998;142:1279-87
110. Betto R, Senter L, Ceoldo S, et al: Ecto-ATPase activity of α-sarcoglycan (Adhalin). J Biol Chem 1999;274:7907-12
111. Straub V, Rafael JA, Chamberlain JS, et al: Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 1997;139:375-85
112. Cohn RD, Mayer U, Saher G, et al: Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. J Neurol Sci 1999;163:140-52
113. Saher G, Hildt E: Activation of c-Raf-1 kinase signal transduction pathway in alpha(7) integrin-deficient mice. J Biol Chem 1999;274:27651-7
114. Hodges BL, Hayashi YK, Nonaka I, et al: Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J Cell Sci 1997;110(pt 22):2873-81
115. Hayashi YK, Chou FL, Engvall E, et al: Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet 1998;19:94-7
116. Mayer U, Saher G, Fassler R, et al: Absence of integrin α7 a novel from of muscular dystrophy. Nat Genet 1997;17:318-23
117. Moll J, Barzaghi P, Lin S, et al: An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 2001;413:302-7
118. Mendell JR, Engel WK, Derrer EC: Duchenne muscular dystrophy: Functional ischemia reproduces its characteristic lesions. Science 1971;172:1143-5
119. Brown RH: Free radicals, programmed cell death and muscular dystrophy. Curr Opin Neurobiol 1995;8:373-8
120. Austin L, de Niese M, McGregor A, et al: Potential oxyradical damage and energy status in individual muscle fibres from degenerating muscle diseases. Neuromuscul Disord 1992;2:27-33
121. Asayama K, Hayashibe H, Dobashi K, et al: Lipid peroxide and antioxidant enzymes in muscle and nonmuscle of dystrophic mouse. Muscle Nerve 1989;12:742-8
122. Hauser E, Hoger H, Bittner R, et al: Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. Neuropediatrics 1995;26:260-2
123. 2+ metabolism. Med Hypotheses 1989;29:187-93
124. Austin L: How the lack of dystrophin may upset calcium regulation and lead to oxidative damage, in: Kakulas BA, Mastaglia FL (eds): Pathogenesis and Therapy of Duchenne and Becker Muscular Dystrophy. New York, Raven Press, 1999, pp 69-82
125. Reid MB, Haack KE, Franchek KM, et al: Reactive oxygen in skeletal muscle: I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol 1992;73:1797-804
126. Reid MB, Shoji T, Moody MR, et al: Reactive oxygen in skeletal muscle: II. Extracellular release of free radicals. J Appl Physiol 1991;73:1805-9
127. Haycock JW, Mac Neil S, Mantle D: Differential protein oxidation in Duchenne and Becker muscular dystrophy. NeuroReport 1998;9:2201-7
128. Ragusa RJ, Chow CK, Porter JD: Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul Disord 1997;7:379-86
129. Disatnik MH, Dhawan J, Yu Y, et al: Evidence of oxidative stress in mdx mouse muscle: Studies of the pre-necrotic state. J Neurol Sci 1998;161:77-84
130. Rando TA, Disatnik MH, Yu Y, et al: Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 1998;8:14-21
131. Disatnik MH, Chamberlain JS, Rando TA: Dystrophin mutations predict cellular susceptibility to oxidative stress. Muscle Nerve 2000;23:784-92
132. Sander M, Chavoshan B, Harris SA, et al: Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci USA 2000;97:13818-23
133. Coral-Vazquez R, Chon RD, Moore SA, et al: Disruption of the sarcoglycansarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy. Cell 1998;98:465-74
134. Durbeej M, Cohn RD, Hrstka RF, et al: Disruption of the β-sarcoglycan gene reveals pathogenetic complexity of limbgirdle muscular dystrophy type 2E. Mol Cell 2000;5:141-51
135. Factor SM, Minase T, Cho S, et al: Microvascular spasm in the cardiomyopathic Syrian Hamster: A preventable cause of focal myocardial necrosis. Circulation 1982:342-54
136. Greenberg DS, Sunada Y, Campbell KP, et al: Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat Genet 1994;8:340-4
137. Cox GA, Sunada Y, Campbell KP, et al: Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet 1994;8:333-9
138. Hoffman EP: Dystrophin associated proteins fail in filling dystrophin's shoes. Nat Genet 1994;8:311-2